Covered recipient · General Payments record
JESSIKA SANZ
General Payments · PY2024
$864.10
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $864.10 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $460.56 | 11 |
| Lilly USA, LLC | $84.72 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $57.51 | 1 |
| Arcutis Biotherapeutics, Inc. | $48.49 | 1 |
| Dermavant Sciences, Inc. | $47.81 | 2 |
| GENZYME CORPORATION | $38.23 | 1 |
| Galderma Laboratories, L.P. | $36.78 | 1 |
| Almirall LLC | $31.50 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.63 | 1 |
| Incyte Corporation | $16.81 | 1 |
| Amgen Inc. | $15.06 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $864.10 | 25 |
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $45.42 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019019 | CMS |
| ABBVIE INC. | $21.87 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019021 | CMS |
| ABBVIE INC. | $29.27 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019023 | CMS |
| ABBVIE INC. | $24.67 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019025 | CMS |
| ABBVIE INC. | $124.99 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019027 | CMS |
| ABBVIE INC. | $8.62 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019029 | CMS |
| ABBVIE INC. | $6.22 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019031 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019033 | CMS |
| ABBVIE INC. | $140.03 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019035 | CMS |
| ABBVIE INC. | $26.74 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019037 | CMS |
| ABBVIE INC. | $27.83 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106019039 | CMS |
| Almirall LLC | $31.50 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120642571 | CMS |
| Amgen Inc. | $15.06 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117374633 | CMS |
| Arcutis Biotherapeutics, Inc. | $48.49 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121054025 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118015398 | CMS |
| Dermavant Sciences, Inc. | $24.29 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127928357 | CMS |
| Dermavant Sciences, Inc. | $23.52 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127928361 | CMS |
| Galderma Laboratories, L.P. | $36.78 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145326141 | CMS |
| GENZYME CORPORATION | $38.23 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140004848 | CMS |
| Incyte Corporation | $16.81 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141194113 | CMS |
| Lilly USA, LLC | $24.17 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135048110 | CMS |
| Lilly USA, LLC | $23.42 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135021166 | CMS |
| Lilly USA, LLC | $23.04 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135048112 | CMS |
| Lilly USA, LLC | $14.09 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135048658 | CMS |
| Novartis Pharmaceuticals Corporation | $57.51 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087337647 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.